"Use Of Complement Factor D Inhibitor For Treatment Of Geographic Atrophy Secondary To Age-Related Macular Degeneration" in Patent Application Approval Process (USPTO 20240252497).

MLA

“‘Use Of Complement Factor D Inhibitor For Treatment Of Geographic Atrophy Secondary To Age-Related Macular Degeneration’ in Patent Application Approval Process (USPTO 20240252497).” Drug Week, Aug. 2024, p. 3425. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=179025402&authtype=sso&custid=ns315887.

APA

“Use Of Complement Factor D Inhibitor For Treatment Of Geographic Atrophy Secondary To Age-Related Macular Degeneration” in Patent Application Approval Process (USPTO 20240252497). (2024). Drug Week, 3425.

Chicago

“‘Use Of Complement Factor D Inhibitor For Treatment Of Geographic Atrophy Secondary To Age-Related Macular Degeneration’ in Patent Application Approval Process (USPTO 20240252497).” 2024. Drug Week, August, 3425. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=179025402&authtype=sso&custid=ns315887.